News
Axio BioPharma, a trusted innovator and provider of high-quality recombinant proteins, is excited to announce that it is now accepting recombinant protein manufacturing projects. Located within ...
Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation ...
Medtech startup Axio Biosolutions has raised $5.2 Mn (INR 36 Cr) in Series B-1 round led by Omidyar Network India. Axio’s existing investors Accel, University of California, Ratan Tata-backed ...
Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation technologies, ...
Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. MADISON, WI and KANSAS CITY, MO, June 9, 2025 - ...
Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery PR Newswire MADISON, Wis. and KANSAS CITY, Mo., June 9, 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results